GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HAEMATO AG (XTER:HAEK) » Definitions » Additional Paid-In Capital

HAEMATO AG (XTER:HAEK) Additional Paid-In Capital : €112.6 Mil(As of Jun. 2023)


View and export this data going back to 2005. Start your Free Trial

What is HAEMATO AG Additional Paid-In Capital?


HAEMATO AG's quarterly additional paid-in capital stayed the same from Jun. 2022 (€112.6 Mil) to Dec. 2022 (€112.6 Mil) and stayed the same from Dec. 2022 (€112.6 Mil) to Jun. 2023 (€112.6 Mil).

HAEMATO AG's annual additional paid-in capital increased from Dec. 2020 (€98.6 Mil) to Dec. 2021 (€112.6 Mil) but then stayed the same from Dec. 2021 (€112.6 Mil) to Dec. 2022 (€112.6 Mil).

HAEMATO AG Additional Paid-In Capital Historical Data

The historical data trend for HAEMATO AG's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HAEMATO AG Additional Paid-In Capital Chart

HAEMATO AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.37 22.37 98.57 112.58 112.58

HAEMATO AG Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 112.58 112.58 112.58 112.58 112.58

HAEMATO AG Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

HAEMATO AG Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of HAEMATO AG's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

HAEMATO AG (XTER:HAEK) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HAEMATO AG (XTER:HAEK) » Definitions » Additional Paid-In Capital
Comparable Companies
XTER:B8F XTER:PA8 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX SZSE:000963 SHSE:600085 XPAR:IPN SHSE:600196
Traded in Other Exchanges
HAEK:Germany HAEK:Germany HAEK:Germany
Address
Lilienthalstrasse 5c, Schonefeld, DEU, D-12529
Website
https://www.haemato.ag
HAEMATO AG is a Germany based pharmaceutical company. It provides pharmaceuticals for the care of chronically ill people. The firm is engaged in the sale of generic and EU (European countries) import drugs. It is focused on patented and non-patented medicinal products. The company product portfolio includes human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), neurology, oncology, rheumatology, and urology. Geographically, it operates only in Germany.

HAEMATO AG (XTER:HAEK) Headlines

No Headlines